iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Update

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 8,781 shares, a growth of 30.1% from the January 15th total of 6,747 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 52,967 shares, the short-interest ratio is presently 0.2 days. Based on an average daily volume of 52,967 shares, the short-interest ratio is presently 0.2 days. Currently, 0.2% of the shares of the company are short sold.

Hedge Funds Weigh In On iShares Genomics Immunology and Healthcare ETF

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Triumph Capital Management acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the 3rd quarter worth $35,000. Ameriprise Financial Inc. lifted its position in iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after purchasing an additional 5,540 shares during the period. Portland Global Advisors LLC grew its stake in iShares Genomics Immunology and Healthcare ETF by 0.7% during the third quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after buying an additional 684 shares in the last quarter. Finally, Flow Traders U.S. LLC bought a new position in iShares Genomics Immunology and Healthcare ETF in the 2nd quarter valued at about $931,000.

iShares Genomics Immunology and Healthcare ETF Trading Up 1.5%

Shares of IDNA opened at $29.51 on Wednesday. iShares Genomics Immunology and Healthcare ETF has a 12 month low of $17.26 and a 12 month high of $30.30. The firm’s 50 day moving average is $27.84 and its 200-day moving average is $25.44. The stock has a market capitalization of $147.55 million, a PE ratio of 14.76 and a beta of 1.07.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.